We are live on ! Find out more
PC

Polar Capital Portfolio holdings

AUM $13.5B
1-Year Est. Return 55.9%
This Fund
S&P 500
This Quarter Est. Return
+7.79%
1 Year Est. Return
+55.9%
3 Year Est. Return
+127.44%
5 Year Est. Return
+269.08%
10 Year Est. Return
–
AUM
$5.13B
AUM Growth
+$358M
Cap. Flow
+$4.93M
Cap. Flow %
0.1%
Top 10 Hldgs %
21.38%
Holding
316
New
42
Increased
108
Reduced
79
Closed
41

Top Buys

Rank Stock Value
1
ACN icon
Accenture
ACN
+$28.9M
2
TWX
Time Warner Inc
TWX
+$28.6M
3
PRGO icon
Perrigo
PRGO
+$28.5M
4
RL icon
Ralph Lauren
RL
+$28.5M
5
LVNTA
Liberty Interactive Corporation Series A Liberty Ventures
LVNTA
+$28.1M

Top Sells

Rank Stock Value
1
IMO icon
Imperial Oil
IMO
+$40.7M
2
CELG
Celgene Corp
CELG
+$29.8M
3
V icon
Visa
V
+$28.3M
4
CMI icon
Cummins
CMI
+$26M
5
HSIC icon
Henry Schein
HSIC
+$25.4M

Sector Composition

Rank Sector Weight
1 Technology 25.64%
2 Financials 21.45%
3 Healthcare 20.19%
4 Communication Services 11.21%
5 Industrials 6.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TWO
201
Two Harbors Investment
TWO
$1.27B
$1.8M 0.04%
22,500
+1,875
+9% +$152K
DHC
202
Diversified Healthcare Trust
DHC
$2.28B
$1.77M 0.03%
80,720
-10,090
-11% -$221K
NHI icon
203
National Health Investors
NHI
$3.84B
$1.75M 0.03%
25,000
-10,000
-29% -$650K
HSTO
204
DELISTED
Histogen Inc. Common Stock
HSTO
$1.75M 0.03%
1,250
– –
HR
205
DELISTED
Healthcare Realty Trust Incorporated
HR
$1.64M 0.03%
60,000
– –
REGN icon
206
Regeneron Pharmaceuticals
REGN
$69.9B
$1.62M 0.03%
3,946
-56,291
-93% -$22.1M
TMUSP
207
DELISTED
T-Mobile US, Inc.5.50% Mandatory Convertible Preferred Stock, Series A
TMUSP
– –
0
– –
WT icon
208
WisdomTree
WT
$3.01B
$1.52M 0.03%
97,051
-351
-0.4% -$4.88K
SBRA icon
209
Sabra Healthcare REIT
SBRA
$5.65B
$1.52M 0.03%
50,000
– –
AA.PRB
210
DELISTED
Alcoa Inc
AA.PRB
– –
0
– –
EVOL
211
DELISTED
Evolving Systems, Inc.
EVOL
$1.36M 0.03%
146,004
-43,465
-23% -$433K
HCSG icon
212
Healthcare Services Group
HCSG
$1.58B
$1.19M 0.02%
38,372
– –
ICPT
213
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$1.16M 0.02%
7,442
+5,787
+350% +$1.07M
BDX icon
214
Becton Dickinson
BDX
$43.8B
$1.11M 0.02%
8,200
-2,050
-20% -$262K
BAX icon
215
Baxter International
BAX
$12.1B
$1.1M 0.02%
27,615
– –
YOKU
216
DELISTED
YOUKU TUDOU INC.(CAYMAN ISLS)
YOKU
$1.06M 0.02%
+59,850
New +$1.11M
GILD icon
217
Gilead Sciences
GILD
$162B
$1.05M 0.02%
11,160
+3,565
+47% +$369K
HDB icon
218
HDFC Bank
HDB
$119B
$1.03M 0.02%
81,520
– –
HCA icon
219
HCA Healthcare
HCA
$86.4B
$1.03M 0.02%
14,000
-145,900
-91% -$10.3M
UNH icon
220
UnitedHealth
UNH
$379B
$1.01M 0.02%
10,000
+2,000
+25% +$190K
ALXN
221
DELISTED
Alexion Pharmaceuticals
ALXN
$997K 0.02%
5,390
-88,743
-94% -$16.4M
GEVA
222
DELISTED
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
$954K 0.02%
+10,284
New +$812K
CMRX
223
DELISTED
Chimerix, Inc.
CMRX
$902K 0.02%
22,403
+6,744
+43% +$228K
CVS icon
224
CVS Health
CVS
$137B
$867K 0.02%
9,000
– –
ACAD icon
225
Acadia Pharmaceuticals
ACAD
$4.35B
$747K 0.01%
23,542
+14,933
+173% +$423K
7 8
9
10 11

Similar funds

ECM
ETrade Capital Management Arlington, Virginia $5.37B AUM 10.84% 1-Year Est. Return
FAAS
First Allied Advisory Services San Diego, California $2.98B AUM 15.89% 1-Year Est. Return
WAM
Wealthspire Advisors (Maryland) Potomac, Maryland $2.84B AUM 10.91% 1-Year Est. Return
FS
Feinberg Stephen $2.61B AUM 15.12% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
TI
TT International London, United Kingdom $1.94B AUM
VIM
Veritas Investment Management London, United Kingdom $1.65B AUM 25.54% 1-Year Est. Return
PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return

Polar Capital's Q4 2014 Portfolio in Review

As of Q4 2014, Polar Capital held 316 positions worth $5.13B, up 7.5% from $4.77B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Polar Capital's Q4 2014 filing shows 42 new, 108 increased, 79 reduced and 41 closed positions. Its largest new stake was Accenture: 348,091 shares worth $31.1M. The largest sale was Imperial Oil, an estimated $40.7M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Financials and Healthcare.

  • Polar Capital's largest Q4 2014 buy was Accenture: 348,091 shares worth $31.1M.
  • Polar Capital added most to Time Warner Inc in Q4 2014, an estimated $28.6M increase.
  • Polar Capital's biggest Q4 2014 reduction was Celgene Corp, cutting an estimated $29.8M.
  • Polar Capital fully exited Imperial Oil in Q4 2014, selling an estimated $40.7M.
  • Polar Capital's ten largest holdings make up 21% of its $5.13B portfolio in Q4 2014.
  • Polar Capital opened 42 new positions and closed 41 in Q4 2014.
  • Polar Capital's portfolio value rose 7.5% quarter-over-quarter to $5.13B.

Based on Polar Capital's 13F filing for Q4 2014, filed 17 Feb 2015.